Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your heart health at home. Here are the tools they suggest (and who they most ...

Glucotrack has successfully completed its first in-human clinical study for the first real-time, continuous blood glucose monitor (CBGM) placed in the subclavian vein.

Medical experts said such an innovative monitoring method, may significantly enhance patients' compliance to blood glucose monitoring regularly and improve their quality of life.

Gonzaga University and the UW School of Medicine hosted Irl Hirsch to lecture about the future of glucose monitoring.

Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...

Researchers have devised a revolutionary, noninvasive method to monitor blood glucose, allowing for accurate measurements of ...

Shanghai's Ruijin Hospital announced today that researchers have developed a groundbreaking non-invasive blood glucose ...

New research suggests that wearing continuous glucose monitors could lower the risk of dementia. Experts discuss how symptoms ...

A three-year, $1.4m project aims to address inequities experienced by Māori and Pacific people with type 1 diabetes.